Intellia Therapeutics (NTLA) Q1 2025 Earnings

27FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.52
-1.39
-1.25
-1.12

Details

Expected EPS
-1.330728
Actual EPS
-1.27
Surprise EPS
0.06
Surprise Percent
+4.56%

Description

Intellia Therapeutics (NTLA) has reported earnings of -1.27 per share for Q1 2025.

0 Comments

Share your thoughts